LEPR and central nervous system cancer: Furthermore, it has been demonstrated that LDFI, a peptide able to block ObR, along with AG490, a JAK2/STAT3 inhibitor, is able to reduce leptin-induced NOTCH1 overexpression and transcriptional activity in U87 and T98 glioma cell lines.